Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: November 13, 2025
SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for 18F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: October 14, 2025
SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for 18F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 16, 2025
Diagnostic performance of F-18 flurpiridaz in women: A sub-study of the Aurora Phase 3 trial.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 27, 2025
18F flurpiridaz PET MPI: Imaging characteristics and clinical trials.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: February 11, 2025
Comparison, Agreement, and Significance Cutoffs of 18F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 19, 2024
Reply: 18F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?
Journal: Journal of the American College of Cardiology
Published: November 29, 2023
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
Journal: Journal of the American College of Cardiology
Published: March 22, 2023
Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 01, 2021
18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization.
Journal: European heart journal. Cardiovascular Imaging
Published: June 22, 2021
Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: November 23, 2020
Development, diagnostic performance, and interobserver agreement of a 18F-flurpiridaz PET automated perfusion quantitation system.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: July 20, 2020
Last Updated: 09/26/2026